ARROWHEAD PHARMACEUTICALS, INC. — Director's Dealing 2019

Jan 12, 2019

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ARROWHEAD PHARMACEUTICALS, INC. (ARWR)
CIK: 0000879407
Period of Report: 2019-01-11

Reporting Person: Waddill William D. (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2019-01-11	Common Stock	S	8500	$14.77	Disposed	46500	Direct

Footnotes

F1: The sale was made to generate proceeds to cover the tax liability incident to the vesting of restricted stock units.